ArticleFrontiers in epidemiology2025
Assessing the long-term persistence of SARS-CoV-2 in Guinea: insights from post-epidemic sentinel syndromic surveillance data.
Article in Frontiers in epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Strengthening microbial genomics capacity in Africa for epidemic preparedness: key lessons from the AFROSCREEN programme.Journal of global health · 2026Article
- Two years of SARS-CoV-2 genomic surveillance capacity development in Guinea.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In December 2019, the world experienced one of the significant health crises of the 21st century with the emergence and rapid spread of the potentially fatal 2019 coronavirus (COVID-19). In this context, sentinel surveillance of SARS-CoV-2 variants was conducted in Conakry. Here we report the first data on reproduction numbers and risk factors during the Omicron post-epidemic period in Guinea. Methods: A sentinel syndromic and genomic surveillance study was conducted on suspected patients from October 2022 to July 2024 at healthcare facilities in Conakry. Individual data and nasopharyngeal swabs were collected and sent to the Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG) laboratory for screening and sequencing by next-generation sequencing (NGS). The effective reproduction number (Rt) were estimated using EpiEstim to assess the transmission potential of the Omicron variant. Generalized linear models based on the binomial distribution were employed to analyze factors associated with SARS-CoV-2 positivity, following the identification of primary risk factors using Bayesian model averaging and the Data balancing algorithm using propensity score matching. Results: Data from 1174 patients with suspected cases with a median age of 31 years (IQR: 20-51), were analyzed. The overall COVID-19 positivity rate was 11.8%. The global effective reproduction number (Rt) was 2.08 [95% CI: 0.35-5.81]. Only ageusia [AOR = 2.0; 95% CI (1.1-3.6)] was independently associated with SARS-CoV-2 test positivity. Conclusion: SARS-CoV-2 is still circulating in Guinea, with a high positivity rate and a high number of effective reproductions in this post-epidemic period in our country. The associated factors and the circulation of variants with a diversity of circulating strains suggest the need to strengthen genomic and epidemiological surveillance, with the support of all those involved in the response to COVID-19, to ensure continuity of alerts and decision-making for public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.